Biote (BTMD) Short-Term Debt issuances (2024 - 2026)
Biote's quarterly Short-Term Debt issuances came in at $7.5 million in Q1 2026, up 50.0% quarter-over-quarter from $5.0 million in Q4 2025.
Biote has reported Short-Term Debt issuances for 3 years, with the latest figure at $7.5 million in Q1 2026.
- For the quarter ending Q1 2026, Short-Term Debt issuances changed N/A year-over-year to $7.5 million; the trailing twelve-month figure through Mar 2026 stood at $12.5 million (up 25.0% YoY), and the FY2025 full-year result was $5.0 million, changed N/A from the prior year.
- Short-Term Debt issuances for Q1 2026 stood at $7.5 million, up from $5.0 million in the prior quarter.
- The five-year high for Short-Term Debt issuances was $10.0 million in Q2 2024, with the low at $5.0 million in Q4 2025.
- Average Short-Term Debt issuances over 3 years is $7.5 million, with a median of $7.5 million recorded in 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | 1.44 Bn |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | - |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | - |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | - |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | - |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | 40,000.00 |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | - |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | -493,000.00 |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | 45.00 Mn |
| 10 | Biote | 61.29 Mn | 64.11 Mn | 30.95 Mn | 7.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.50 Mn |
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Jun 30, 2024 | 10.00 Mn |
| Jun 30, 2024 | 10.00 Mn |